Condition

Takayasu Arteritis (TAK) (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

AbbVie (1)

Collaborator

Intervention

placebo for upadacitinib (1)

prednisolone (1)

upadacitinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

takayasu arteritis (tak)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Takayasu Arteritis (TAK) Trial in Worldwide (Upadacitinib, Placebo for Upadacitinib, Prednisolone)

Recruiting

Takayasu Arteritis (TAK)

Upadacitinib
+2 more

Salvador, Bahia, Brazil
+44 more

Aug 22, 2022